Coronary vasodilator capacity and epicardial vessel remodeling in physiological and hypertensive hypertrophy

M Kozàkovà1, F Galetta, L Gregorini

  • 1Institute of Clinical Physiology, CNR, University of Pisa, Italy.

Insights

Physiological hypertrophy from exercise preserves coronary vasodilator capacity, unlike hypertensive hypertrophy. Athletes maintain normal coronary flow and oxygen demand relationships, while hypertensive patients show impaired vasodilation.

Area of Science:

  • Cardiology
  • Physiology
  • Exercise Science

Background:

  • Left ventricular hypertrophy (LVH) can result from physiological (athlete's heart) or pathological (hypertensive) causes.
  • Understanding the impact of different LVH types on coronary circulation is crucial for cardiovascular health assessment.

Purpose of the Study:

  • To compare coronary blood flow, myocardial oxygen demand, and vasodilator capacity in individuals with physiological, exercise-induced, and hypertensive left ventricular hypertrophy.
  • To investigate the relationship between resting coronary flow and determinants of oxygen demand across different hypertrophy types.

Main Methods:

  • Utilized transesophageal and transthoracic Doppler echocardiography to assess coronary flow velocity and artery dimensions.
  • Measured coronary flow velocity in the left anterior descending artery and left main artery cross-sectional area at rest and during dipyridamole-induced vasodilation.
  • Estimated myocardial oxygen demand using rate-pressure product, left ventricular wall stress, and inotropic function.

Main Results:

  • Athletes with physiological hypertrophy demonstrated preserved coronary flow reserve and normal minimum coronary resistance, comparable to sedentary individuals.
  • Hypertensive subjects exhibited decreased coronary flow reserve and increased minimum coronary resistance.
  • Left main artery dilation was significantly greater in athletes compared to sedentary and hypertensive groups, indicating enhanced macrocirculation vasodilator capacity.

Conclusions:

  • Coronary microcirculation vasodilator capacity is not impaired in athletes with physiological hypertrophy, contrasting with hypertensive hypertrophy.
  • The relationship between resting coronary flow velocity and oxygen demand determinants is maintained in physiological hypertrophy but lost in hypertensive hypertrophy.
  • Exercise-induced adaptations enhance coronary macrocirculation vasodilator capacity in trained individuals.

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
Antihypertensive Drugs: Vasodilators01:23

Antihypertensive Drugs: Vasodilators

Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...